{"id":88504,"date":"2019-03-08T18:22:57","date_gmt":"2019-03-09T02:22:57","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/03\/fda-approves-1st-immunotherapy-drug-to-treat-breast-cancer"},"modified":"2019-03-08T18:22:57","modified_gmt":"2019-03-09T02:22:57","slug":"fda-approves-1st-immunotherapy-drug-to-treat-breast-cancer","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/03\/fda-approves-1st-immunotherapy-drug-to-treat-breast-cancer","title":{"rendered":"FDA approves 1st immunotherapy drug to treat breast cancer"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/fda-approves-1st-immunotherapy-drug-to-treat-breast-cancer2.jpg\"><\/a><\/p>\n<p>The U.S. Food and Drug Administration has approved the first immunotherapy drug for breast cancer.<\/p>\n<p>Continue Reading Below<\/p>\n<p>Swiss drugmaker Roche\u2019s Tecentriq was OK\u2019d Friday for treating advanced triple-negative breast cancer, which accounts for about 15 percent of cases. It\u2019s to be given with chemotherapy, the standard treatment.<\/p>\n<p><!-- Link: <a href=\"https:\/\/www.foxbusiness.com\/markets\/fda-approves-1st-immunotherapy-drug-to-treat-breast-cancer\">https:\/\/www.foxbusiness.com\/markets\/fda-approves-1st-immunot...ast-cancer<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Food and Drug Administration has approved the first immunotherapy drug for breast cancer. Continue Reading Below Swiss drugmaker Roche\u2019s Tecentriq was OK\u2019d Friday for treating advanced triple-negative breast cancer, which accounts for about 15 percent of cases. It\u2019s to be given with chemotherapy, the standard treatment.<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-88504","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/88504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=88504"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/88504\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=88504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=88504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=88504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}